HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
94
|
101 |
GCKR |
Q14397
|
glucokinase regulator
|
|
8.5E-19 |
0.604 |
0.615 |
79
|
13 |
SH2B3 |
Q9UQQ2
|
SH2B adaptor protein 3
|
|
1.0E-04 |
0.527 |
0.692 |
74
|
8 |
FADS2 |
O95864
|
fatty acid desaturase 2
|
|
1.00 |
0.575 |
0.692 |
74
|
50 |
FADS1 |
O60427
|
fatty acid desaturase 1
|
|
0.37 |
0.582 |
0.769 |
53
|
30 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
48
|
44 |
RAD51B |
O15315
|
RAD51 paralog B
|
|
2.1E-15 |
0.556 |
0.769 |
46
|
41 |
IRF1-AS1 |
Q8N8D9
|
IRF1 antisense RNA 1
|
|
4.2E-03 |
0.670 |
0.385 |
41
|
26 |
BACH2 |
Q9BYV9
|
BTB domain and CNC homolog 2
|
|
1.00 |
0.539 |
0.731 |
41
|
29 |
MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
38
|
56 |
JMJD1C |
Q15652
|
jumonji domain containing 1C
|
|
1.00 |
0.517 |
0.769 |
35
|
48 |
CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
35
|
41 |
PTPN22 |
Q9Y2R2
|
protein tyrosine phosphatase non-receptor type 22
|
|
3.5E-21 |
0.438 |
0.846 |
34
|
1 |
CCDC26 |
Q8TAB7
|
CCDC26 long non-coding RNA
|
|
|
0.647 |
0.615 |
31
|
41 |
HECTD4 |
Q9Y4D8
|
HECT domain E3 ubiquitin protein ligase 4
|
|
1.00 |
0.700 |
0.462 |
31
|
11 |
CLEC16A |
Q2KHT3
|
C-type lectin domain containing 16A
|
|
0.28 |
0.612 |
0.654 |
29
|
38 |
RERE |
Q9P2R6
|
arginine-glutamic acid dipeptide repeats
|
|
1.00 |
0.526 |
0.846 |
29
|
32 |
PNKD |
Q8N490
|
PNKD metallo-beta-lactamase domain containing
|
|
4.1E-08 |
0.615 |
0.615 |
28
|
17 |
PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
27
|
31 |
RREB1 |
Q92766
|
ras responsive element binding protein 1
|
|
1.00 |
0.500 |
0.808 |
27
|
23 |
KANSL1 |
Q7Z3B3
|
KAT8 regulatory NSL complex subunit 1
|
|
1.00 |
0.592 |
0.731 |
25
|
15 |
TNXB |
P22105
|
tenascin XB
|
|
1.9E-02 |
0.572 |
0.731 |
24
|
26 |
HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
23
|
17 |
MIR3936HG |
|
MIR3936 host gene
|
|
|
0.861 |
0.269 |
22
|
18 |